Stem cell center studies ways to protect egg donors
By San Francisco Examiner,
San Francisco Examiner
| 11. 02. 2005
Officials at California_s new stem cell institute say they are determined to figure out the best way to protect the health of women who donate their eggs for medical research, the first time a public agency in the U.S. has addressed that question.
Currently, said Zach Hall, president of the California Institute for Regenerative Medicine, there is no consensus about how egg harvesting affects a woman_s health, and whether some egg-inducing hormones pose a serious risk to donors. The CIRM, which was created after state voters approved Proposition 71 last fall, must have a better understanding of those risks before it can set policies governing egg donations, Hall said.
_We believe it is our responsibility to become better informed _ to look critically at the evidence,_ Hall told the CIRM board at its meeting in San Francisco on Wednesday. _What is the data? What is the best end? What are the best practices to reduce risks?_
To answer those questions, Hall said, the CIRM must first simply study the science. To that end, the agency will organize a one-day scientific...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...